Zydus has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at its manufacturing facility located at Pharmez, Ahmedabad from March 20 to 24, 2023, the company announced on Mo0nday through an exchange filing.
The inspection has been classified as Voluntary Action Indicated (VAI). The EIR report indicates that the inspection is closed.
Zydus Shares
The shares of Zydus on Monday at 11:18 am IST were at Rs 590.85, up by 1.34 percent.
UP News: Lucknow To Host 19th Bharat Scouts And Guides National Jamboree After 61 Years; Event To Blend Tradition, Technology & Youth Leadership
Uttar Pradesh Becomes World’s First AI-Driven Governance Pilot Site Under Yogi Adityanath’s Leadership, Sets Global Benchmark In Innovation
IIHMR University Partners With Bryant University To Boost Global Academic Collaboration
Yami Gautam Dons ₹118,999 Mustard Yellow Kurta Set For Haq Promotions
